Changing attitudes in ovarian stimulation

Women's Health

Volumn 7, Issue 5, 2011, Pages 505-507

  Al Inany, Hesham ^a   Wahba, Amr ^a   Peitsidis, Panagiotis ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b HELENA VENIZELOU HOSPITAL   (Greece)

Author keywords

GnRH antagonist; infertility; IVF; live birth; ovarian hyperstimulation syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN RECEPTOR; HORMONE RECEPTOR; LUTEINIZING HORMONE;

ALLERGIC REACTION; ATTITUDE TO CHANGE; CLINICAL PROTOCOL; DESENSITIZATION; DOWN REGULATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GONADOTROPIN RELEASE; HOT FLUSH; HUMAN; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; REVIEW; SINGLE DRUG DOSE; SLEEP DISORDER;

CHORIONIC GONADOTROPIN; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE CONTROL AGENTS;

EID: 80052501594     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.51     Document Type: Review

References (13)

1. Al-Inany H, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst. Rev. 4, CD001750 (2003).
2. Rizk B, Smitz J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum. Reprod. 7(3), 320-327 (1992).
3. Rizk B, Aboulghar MA. Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In:A Textbook of In Vitro Fertilization and Assisted Reproduction . Brinsden P (Ed.).The Parthenon Publishing Group, New York, NY, USA (1999).
4. Felberbaum RE, Reissmann T, Kuper W et al. Preserved pituitary response under ovarian stimulation with hMG and GnRHntagonists (Cetrorelix) in women with tubal infertility. Eur. J. Obstet. Gynecol. Reprod. Biol. 61(2), 151-155 (1995).
5. Olivennes F, Alvarez S, Bouchard P, Fanchin R, Salat-Baroux J, Frydman R. The use of GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum. Reprod. 13(9), 2411-2414 (1998). (Pubitemid 28451215)
6. Ludwig M, Katalinic A, Banz C et al. Tailoring the GnRH antagonist Cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study. Hum. Reprod. 17(11), 2842-2845 (2002). (Pubitemid 35350899)
7. Olivennes F, Fanchin R, Bouchard P, Taeb J, Selva J, Frydman R. Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in vitro fertilization cycles: a pilot study. Hum. Reprod. 10(6), 1382-1386 (1995).
8. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared with day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J. Clin. Endocrinol. Metab. 88(12), 5632-5637 (2003). (Pubitemid 38033026)
9. Kolibianakis EM, Albano C, Kahn J et al. Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil. Steril. 79(4), 873-880 (2003). (Pubitemid 36385006)
10. Al-Inany H, Aboulghar MA, Mansour RT, Serour GI. Optimizing GnRH antagonist administration: metanalysis of fixed versus flexible protocol. Reprod. Biomed. Online 10(5), 567-570 (2005). (Pubitemid 40645532)
11. Al-Inany H, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst. Rev. 4, CD001750 (2001).
12. Al-Inany HG, Youssef MA, Aboulghar M et al. GnRH antagonists are safer than agonists: an update of a Cochrane review. Hum. Reprod. Update 17(4), 435 (2011).
13. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst. Rev. 3, CD001750 (2006).